Earnings Growth in India: Sliding Nifty vs Rising CCP
marcellus.in · 2025-06-24 · tier T2
Source: Memo · marcellus.in dated 2025-06-24. Auto-generated factual summary. Not investment advice. Verify before acting.
Marcellus Investment Managers contends that its Core Conviction Portfolio (CCP) is positioned to outperform as India's broader market faces a structural earnings slowdown. The Nifty50's earnings growth decelerated sharply to 6% year-over-year in FY25, down from a 24% CAGR during FY21–24 when post-Covid revenge spending and government infrastructure capex drove broad-based recovery. By contrast, Marcellus' CCP portfolio delivered 14% earnings growth in FY25, extending a track record of 17%–18% CAGR through FY24. The manager attributes the earnings gap to its focus on deeply moated companies with superior capital allocation and management quality. Portfolio constituents reinvest 80%–90% of operating cash flows at returns on capital employed of 23%–25%, funding market share gains, margin expansion, and new growth drivers. Examples include Narayana Hrudayalaya's investment in technology and new hospital capacity, Divis Labs' expansion into contrast media and GLP-1 peptide building blocks, and Trent's cost savings and store format innovation. Marcellus expects this earnings growth advantage to persist as macro tailwinds fade and fewer firms achieve mid-teens profit growth. Valuation risk remains material. Nifty50 trades at 21.2x FY26 earnings versus a 20-year average of 16.5x, while CCP's 42x forward multiple reflects 2x higher earnings growth and 2x higher returns on capital. Marcellus supplements low-valuation quality names (e.g., Narayana at entry) with underappreciated growth stories where market expectations underestimate earnings potential (e.g., Trent's store expansion and pilot formats). CCP's forward P/E sits 25% below its six-year average and near its lowest since inception.
Citations · 6
“Nifty50's EPS growth was as high as 24% CAGR compared to its last 20-year (FY05-25) average of 10% CAGR. As revenge spending and the Government's infra capex growth fizzled away in FY25, the growth environment reverted to the more sedate levels we had last seen between FY13 and FY19. In this subdued environment, the Nifty50's earnings growth moderated to 6% in FY25.”
p#8 · confidence 95%
“Marcellus' CCP portfolio's earnings growth rate has been in the range of 17%-18% CAGR until FY24 and held firm at 14% YoY in FY25.”
p#1 · confidence 95%
“Such profit growth is a product of their cash generation (i.e. return on capital employed, ROCE of 23%-25%) and reinvestment of 80%-90% of their operating cash flows through capital allocation initiatives to drive profit growth”
p#19 · confidence 95%
“high valuations (21.2x FY26P/E for Nifty50 currently vs an average of 16.5x for the last 20 years)”
p#9 · confidence 95%
“CCP's forward P/E multiple today is at ~25% discount to its last six year average, and is also near its lowest point since inception.”
p#18 · confidence 95%
“we expect CCP to benefit from: a) focus on deeply moated companies with better quality management teams reallocating cash generated from better ROCEs towards driving market share gains, better profit margins, lower working capital cycles and better asset turns; b) potential for earnings upgrades for our investee firms; and c) an approach towards valuations looking to find underappreciated elements of quality”
p#1 · confidence 90%
Follow this investor
Saurabh Mukherjea
Marcellus · Indian quality compounders
More from Saurabh Mukherjea
Browse all →- Memo
Marcellus shifted CCP away from IT services and consumption toward export manufacturing, healthcare, and quality compounders to hedge AI disruption and domestic growth risks.
Sources & details
PublishedApr 16, 2026
- Memo
Summarized by DailySharpe AI